MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Psychedelic Therapy

  • First Time MDMA Filed for FDA Approval, Questions About Repercussions Unanswered
    First Time MDMA Filed for FDA Approval, Questions About Repercussions Unanswered
    The new drug application (NDA) included results from two randomized, double-blind, placebo-controlled studies, both of which were published in Nature.
    December 14, 2023BY Marina Zhang
  • Trauma: The Ghost in Our Cells—and Fascinating Ways to Heal It | Documentary Series
    Trauma: The Ghost in Our Cells—and Fascinating Ways to Heal It | Documentary Series
    Nearly 70 percent of adults have faced traumatic events; the profound impacts of trauma and its deep-rooted mind-body ...
    November 16, 2023BY NTD Original
  • California Group Gathers Signatures for Ballot Measure to Decriminalize Magic Mushrooms
    California Group Gathers Signatures for Ballot Measure to Decriminalize Magic Mushrooms
    A California organization is hoping to gather enough signatures to place an initiative on the November 2024 ballot ...
    July 22, 2023BY Jill McLaughlin
TOP NEWS
  • NTD 8th International Piano Competition Winners Announced
    NEW By NTD Newsroom
    NTD 8th International Piano Competition Winners Announced
  • New PFAS Pesticides Are Entering Our Food System, Revealing a Conundrum
    1hr By Marina Zhang
    New PFAS Pesticides Are Entering Our Food System, Revealing a Conundrum
  • Putin Meets US Envoys as Russia Halts Strikes on Kyiv for 72 Hours
    2hr By Jacki Thrapp
    Putin Meets US Envoys as Russia Halts Strikes on Kyiv for 72 Hours
  • Labor Day Gas Prices Head for Record High
    3hr By Bill Pan
    Labor Day Gas Prices Head for Record High
  • Here’s What People Get Wrong About Modern Warfare | John Spencer
    7hr By Jan Jekielek, Epoch TV
    Here’s What People Get Wrong About Modern Warfare | John Spencer
  • State Department Says 75 Americans Remain Missing After Nepal-Tibet Flood
    7hr By Dorothy Li
    State Department Says 75 Americans Remain Missing After Nepal-Tibet Flood
  • US Forces Destroy 3 IRGC Oil Tankers After Iran Targets Navy Warships
    8hr By Jacki Thrapp
    US Forces Destroy 3 IRGC Oil Tankers After Iran Targets Navy Warships
  • Court Rules Pentagon Can Proceed With Firing Journalists
    9hr By Naveen Athrappully
    Court Rules Pentagon Can Proceed With Firing Journalists
  • Epoch Readers Divided Over Tariffs on Canada, United Over China Concerns
    10hr By Savannah Hulsey Pointer
    Epoch Readers Divided Over Tariffs on Canada, United Over China Concerns
  • Trump Grants Clemency to 30, White House Pardon Czar Says
    11hr By Kimberly Hayek
    Trump Grants Clemency to 30, White House Pardon Czar Says
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top